Effects of temozolomide in malignant brain tumours

Lancet

Volumn 356, Issue 9226, 2000, Pages 342-

  Osoba, D ^a  

^a NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROCARBAZINE; TEMOZOLOMIDE;

CLINICAL TRIAL; GLIOBLASTOMA; HUMAN; LETTER; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 0034702567     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)73628-X     Document Type: Letter

References (3)

1. T Batchelor Temozolomide for malignant brain tumours Lancet 355 2000 1115 1215
2. D Osoba M Brada WK Yung M Prados Health‐related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme J Clin Oncol 18 2000 1481 1491
3. Osoba D, Brada M, Yung WKA, Prados M. Health‐related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide. Eur J Cancer (in press).